Long
Zaktualizowano

Trevena in for a bull run.

Waiting for the NDA resubmission news. Expecting the company presentation in 2020 BIO CEO & Investor Conference on Feb 11, 2020, to cause the market to move upward.
In a possible future FDA approval for their IV oliceridine drug will cause a nice Trend up. Holding all Longs and Share positions.
Zlecenie aktywne
snapshot

Support zone tested and retraced, still showing bullish signs.
Uwaga
snapshot

Bullshit Flag next Target is 1.95

Wyłączenie odpowiedzialności